SNY
Sanofi (SNY)
Healthcare • NASDAQ • $43.31+0.30%
- Symbol
- SNY
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Price
- $43.31
- Daily Change
- +0.30%
- Market Cap
- $103.76B
- Trailing P/E
- 18.59
- Forward P/E
- 8.35
- 52W High
- $53.36
- 52W Low
- $42.78
- Analyst Target
- $55.90
- Dividend Yield
- +5.59%
- Beta
- 0.28
Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines that includes hepatitis A, typhoid, yellow fever, and rabies vaccines. It has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for treatment of alpha-synucleinopathies; and Innate Pharma SA for cell engager program targeting B7-H3. Further, it has a collaboration agreements with Atomwise to use ATOMNET platform and Insili…
Company websiteResearch SNY on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.